Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ark raises L37.4 million

Ark (LSE:AKT) raised L37.4 million ($78.2 million) in

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE